Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
Below are the newest and most recently updated Shortage and Discontinuation reports.
Shortage Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| ZOLMITRIPTAN | PRO DOC LIMITEE | Anticipated shortage | 2.5MG | New Report | 2019-05-21 | 84481 |
| VIRACEPT -250MG | PFIZER CANADA ULC | Anticipated shortage | 250MG | Updated Report | 2019-05-21 | 65178 |
| VIMPAT | UCB CANADA INC | Actual shortage | 10MG | Updated Report | 2019-05-21 | 82479 |
| NITROGLYCERIN IN 5% DEXTROSE INJ.-400MCG/ML | BAXTER CORPORATION | Actual shortage | 5G 40MG | Updated Report | 2019-05-21 | 82898 |
| FUNGIZONE | BRISTOL-MYERS SQUIBB CANADA | Actual shortage | 50MG | Updated Report | 2019-05-21 | 16534 |
| TRICIRA LO | APOTEX INC | Resolved | 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG | Updated Report | 2019-05-21 | 78558 |
| TRICIRA LO | APOTEX INC | Resolved | 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG | Updated Report | 2019-05-21 | 77902 |
| APO-VENLAFAXINE XR | APOTEX INC | Resolved | 75.0MG | Updated Report | 2019-05-21 | 82022 |
| APO-QUINAPRIL | APOTEX INC | Resolved | 5MG | Updated Report | 2019-05-21 | 66623 |
| LABETALOL HYDROCHLORIDE INJECTION USP | PFIZER CANADA ULC | Actual shortage | 5MG | Updated Report | 2019-05-21 | 60109 |
| INNOHEP | LEO PHARMA INC | Resolved | 16000UNIT | Updated Report | 2019-05-21 | 84177 |
| APO-QUINAPRIL | APOTEX INC | Resolved | 40MG | Updated Report | 2019-05-21 | 57808 |
| APO-QUINAPRIL | APOTEX INC | Resolved | 10MG | Updated Report | 2019-05-21 | 66626 |
| APO-MELOXICAM | APOTEX INC | Resolved | 7.5MG | Updated Report | 2019-05-21 | 59302 |
| APO-GABAPENTIN | APOTEX INC | Resolved | 800MG | Updated Report | 2019-05-21 | 79580 |
| APO-EMTRICITABINE-TENOFOVIR | APOTEX INC | Resolved | 300MG 200MG | Updated Report | 2019-05-21 | 80530 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP | STERIMAX INC | Resolved | 500MG | Updated Report | 2019-05-21 | 70380 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP | STERIMAX INC | Resolved | 1G | Updated Report | 2019-05-21 | 80082 |
| ACYCLOVIR SODIUM INJECTION | STERIMAX INC | Actual shortage | 50MG | Updated Report | 2019-05-21 | 78727 |
| CANDESARTAN | SIVEM PHARMACEUTICALS ULC | Anticipated shortage | 8MG | Updated Report | 2019-05-21 | 83176 |
| QUETIAPINE | SIVEM PHARMACEUTICALS ULC | Resolved | 100MG | Updated Report | 2019-05-21 | 80880 |
| MYLAN-TADALAFIL | MYLAN PHARMACEUTICALS ULC | Actual shortage | 10MG | Updated Report | 2019-05-21 | 73957 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | MYLAN PHARMACEUTICALS ULC | Actual shortage | 300MG 200MG | Updated Report | 2019-05-21 | 82201 |
| ELIDEL | VALEANT CANADA LP/VALEANT CANADA S.E.C. | Actual shortage | 1% | Updated Report | 2019-05-21 | 83482 |
| TAZORAC | ALLERGAN INC | Resolved | 0.05% | Updated Report | 2019-05-18 | 65978 |
| RISEDRONATE-35 | SIVEM PHARMACEUTICALS ULC | Actual shortage | 35MG | Updated Report | 2019-05-18 | 83950 |
| HYPURIN NPH INSULIN ISOPHANE PORK | WOCKHARDT UK LTD | Resolved | 100UNIT | Updated Report | 2019-05-18 | 78719 |
| MYLAN-BECLO AQ | MYLAN PHARMACEUTICALS ULC | Actual shortage | 50MCG | Updated Report | 2019-05-18 | 80428 |
| AURO-VENLAFAXINE XR | AURO PHARMA INC | Actual shortage | 150MG | Updated Report | 2019-05-18 | 84288 |
| APO-AMOXI CLAV | APOTEX INC | Resolved | 400MG 57MG | Updated Report | 2019-05-18 | 41 |
| APO-ATORVASTATIN | APOTEX INC | Resolved | 80MG | Updated Report | 2019-05-18 | 84115 |
| AURO-CELECOXIB | AURO PHARMA INC | Actual shortage | 200MG | Updated Report | 2019-05-18 | 84269 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP 1% | HOSPIRA HEALTHCARE ULC | Anticipated shortage | 10MG | New Report | 2019-05-17 | 84418 |
| SEPTA-LOSARTAN | SEPTA PHARMACEUTICALS INC | Actual shortage | 100MG | Updated Report | 2019-05-17 | 70874 |
| SEPTA-LOSARTAN | SEPTA PHARMACEUTICALS INC | Actual shortage | 25MG | Updated Report | 2019-05-17 | 72089 |
| SEPTA-LOSARTAN | SEPTA PHARMACEUTICALS INC | Actual shortage | 50MG | Updated Report | 2019-05-17 | 62907 |
| VENCLEXTA | ABBVIE CORPORATION | Actual shortage | 10MG 100MG 50MG | Updated Report | 2019-05-17 | 84408 |
| VENCLEXTA | ABBVIE CORPORATION | Actual shortage | 100MG | Updated Report | 2019-05-17 | 84405 |
| VENCLEXTA | ABBVIE CORPORATION | Actual shortage | 50MG | Updated Report | 2019-05-17 | 84402 |
| VENCLEXTA | ABBVIE CORPORATION | Actual shortage | 10MG | Updated Report | 2019-05-17 | 84255 |
| APO-CEFPROZIL | APOTEX INC | Actual shortage | Updated Report | 2019-05-17 | 62618 | |
| APO-METHYLPHENIDATE ER | APOTEX INC | Resolved | 18MG | Updated Report | 2019-05-17 | 71136 |
| APO-METHYLPHENIDATE ER | APOTEX INC | Actual shortage | 54MG | Updated Report | 2019-05-17 | 68225 |
| APO-METHYLPHENIDATE ER | APOTEX INC | Actual shortage | 36MG | Updated Report | 2019-05-17 | 70146 |
| APO-METHYLPHENIDATE ER | APOTEX INC | Actual shortage | 27MG | Updated Report | 2019-05-17 | 69918 |
| APO-FENO-SUPER | APOTEX INC | Actual shortage | 100MG | Updated Report | 2019-05-17 | 15268 |
| APO-CICLOPIROX | APOTEX INC | Actual shortage | 8% | Updated Report | 2019-05-17 | 66919 |
| APO-ATOMOXETINE | APOTEX INC | Actual shortage | 10MG | Updated Report | 2019-05-17 | 84108 |
| ROSUVASTATIN | SIVEM PHARMACEUTICALS ULC | Actual shortage | 40MG | Updated Report | 2019-05-17 | 76010 |
| LOSARTAN | SIVEM PHARMACEUTICALS ULC | Anticipated shortage | 100MG | Updated Report | 2019-05-17 | 84342 |
Discontinuation Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| COMBIVENT UDV | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | To be discontinued | 0.2MG 1.0MG | New Report | 2019-05-21 | 84465 |
| ATORVASTATIN-80 | SIVEM PHARMACEUTICALS ULC | To be discontinued | 80MG | Updated Report | 2019-05-21 | 70947 |
| APO-AMOXI CLAV | APOTEX INC | Discontinued | Updated Report | 2019-05-18 | 84392 | |
| APO-CEFPROZIL | APOTEX INC | Discontinued | Updated Report | 2019-05-18 | 84396 | |
| RANITIDINE | SIVEM PHARMACEUTICALS ULC | To be discontinued | 150MG | Updated Report | 2019-05-17 | 76211 |
| PRO-NAPROXEN EC - 375 | PRO DOC LIMITEE | To be discontinued | 375MG | New Report | 2019-05-14 | 84067 |
| ATORVASTATIN-40 | SIVEM PHARMACEUTICALS ULC | To be discontinued | 40MG | Updated Report | 2019-05-13 | 70944 |
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML | APOTEX INC | Discontinued | New Report | 2019-05-13 | 83981 | |
| APO-ALMOTRIPTAN | APOTEX INC | Discontinued | New Report | 2019-05-13 | 83976 | |
| APO-ALMOTRIPTAN | APOTEX INC | Discontinued | New Report | 2019-05-13 | 83971 | |
| PROVERA 2.5MG TABLETS | PFIZER CANADA ULC | Discontinued | 2.5MG | Updated Report | 2019-05-02 | 62399 |
| PROVERA 2.5MG TABLETS | PFIZER CANADA ULC | Discontinued | 2.5MG | Updated Report | 2019-05-02 | 60112 |
| FOLIC ACID INJECTION USP | SANDOZ CANADA INCORPORATED | To be discontinued | 5MG | New Report | 2019-05-01 | 82956 |
| HYDROVAL OINTMENT 0.2% | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. | Discontinued | 0.2% | New Report | 2019-04-30 | 82821 |
| HYDROVAL CREAM 0.2% | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. | Reversed | 0.2% | New Report | 2019-04-30 | 82818 |
| HYDROVAL CREAM 0.2% | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. | Discontinued | 0.2% | New Report | 2019-04-29 | 82607 |
| REPRONEX | FERRING INC | Discontinued | 75UNIT | New Report | 2019-04-27 | 82569 |
| GD-QUINAPRIL | GENMED A DIVISION OF PFIZER CANADA ULC | Discontinued | 20MG | Updated Report | 2019-04-24 | 62050 |
| VOLTAREN SR | NOVARTIS PHARMACEUTICALS CANADA INC | To be discontinued | 100MG | Updated Report | 2019-04-23 | 80298 |
| ATORVASTATIN-10 | SIVEM PHARMACEUTICALS ULC | To be discontinued | 10MG | Updated Report | 2019-04-22 | 70938 |
